Intellia Therapeutics is a startup based in the United States.
Intellia Therapeutics is a startup based in the United States.
Intellia Therapeutics develops genome editing therapies using CRISPR technology to create potentially curative treatments for severe diseases.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.